3 Case studies

 

Success with EECP® Treatment (Case Study No. 1)

72-year-old male patient with two previous myocardial infarctions and bypass surgery

 

 Markedly improved anterior, septal,  and inferior wall perfusion
Evaluation

Ischemic cardiomyopathy

Progressive angina with minimal exertion

100% occlusion of proximal portions
of all three native coronary arteries

Maintained on medical therapy

Outcome

Following 35 sessions (lasting one hour each) of EECP® treatment

Left ventricular ejection fraction (LVEF) increased by 80 percent from baseline

Functional status and chest pain improved markedly

Post-treatment stress test showed improved cardiac perfusion and function

Success with EECP® Treatment (Case Study No. 2)

27-year-old male patient with family history of hyperlipidemia

Evaluation

Presented with exertional angina pectoris

Evaluation revealed

1.5-2.0mm horizontal ST segment depression on exercise treadmill test.

100% occlusion of mid right coronary artery

100% occlusion of mid left anterior descending coronary artery

95% blockages in both proximal mid right coronary artery and small branch of left circumflex coronary artery.

Patient considered not suitable for interventional therapy.

 

Outcome

Following 35 one hour sessions of EECP®

 

Angina completely eliminated at normal levels of exertion.

Posttreatment radionuclide stress testing showed marked improvement in myocardial perfusion.

Success with EECP® Treatment (Case Study No. 3)

72 year old male patient, history of diabetes, gout, hpertension, triple vessel coronary artery disease (CAD)

Evaluation

Presented with stable angina

Previously declined bypass,
maintained on medication.

Stress test suggested progression of CAD.

Severe hypoperfusion of inferior wall
and apex with stress perfusion.

 

Outcome

Following 45 one hour sessions of EECP®

Posttreatment stress testing revealed marked improvement in myocardial perfusion.

Patient showed increased exercise ability.

Chest pain symptoms were eliminated.

Patient no longer required nitroglycerin.

 




Top of page

 

 

 

Vasogenics (U.K) Ltd,
P.O Box 71, Bradford, West Yorkshire BD14 6UL
Telephone 44 (0)1274 201689

Home  About EECP®  EECP Centres®  Links  Angina   Case studies Testimonials Contact us

 

 

 

EECP® is a registered trademark of Vasomedical, Inc., Westbury, New York
Vasogenics is an Authorised Distributor for Vasomedical Inc